The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-21-019 |
| NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) |
93.121 |
RFA-DE-22-001 |
| Maximizing Access to Research Careers (T34 - Clinical Trial Not Allowed) |
93.859 |
PAR-21-147 |
| Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Clinical Centers (Collaborative UG3/UH3 Clinical Trial Required) |
93.307, 93.313, 93.837, 93.840 |
RFA-HL-22-007 |
| Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center (U24 Clinical Trial Required) |
93.307, 93.313, 93.837, 93.840 |
RFA-HL-22-008 |
| Immune Cell Engineering For Targeted Therapy And Disease Monitoring in Type 1 Diabetes (R01 Clinical Trial Not Allowed) |
93.847, 93.855 |
RFA-DK-21-005 |
| Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) |
93.394, 93.395 |
RFA-CA-21-030 |
| Limited Competition: Facility and Building System Upgrades Support for the Regional Biocontainment Laboratories (G20 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-022 |
| Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-007 |
| Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34 - Clinical Trial Not Allowed) |
93.859 |
PAR-21-146 |
| Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) |
93.855, 93.989 |
PAR-21-120 |
| Fogarty Global Trauma and Injury Research Training Program (D43 Clinical Trial Optional) |
93.853, 93.989 |
RFA-TW-21-003 |
| Tobacco Regulatory Science (R01 Clinical Trial Optional) |
93.077 |
RFA-OD-21-002 |
| Basic Research to Inform Vaccine and Therapeutic Development for Non-Polio Human Enteroviruses (NPEV) (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-006 |
| NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional) |
93.867 |
PAR-20-319 |
| NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.286, 93.307, 93.310, 93.350, 93.351, 93.393, 93.394, 93.395, 93.396, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.866, 93.867 |
PA-21-151 |
| Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-080 |
| Human Immunology Project Consortium (U19 Clinical Trial Optional) |
93.855 |
RFA-AI-20-079 |
| Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) |
93.865 |
PAR-21-115 |
| Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed) |
93.351, 93.859 |
PAR-21-125 |
| Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) |
93.351, 93.859 |
PAR-21-127 |
| NIDCR Predoctoral to Postdoctoral Transition Award for a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed) |
93.121 |
PAR-21-060 |
| High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) |
93.351, 93.859 |
PAR-21-126 |
| Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-21-011 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) |
93.273 |
RFA-AA-21-003 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) |
93.273 |
RFA-AA-21-004 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) |
93.273 |
RFA-AA-21-002 |
| High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed) |
93.279 |
RFA-DA-22-006 |
| Early-Phase Clinical Trials of Novel Interventions to Prevent, Delay, or Treat Aging-Related Conditions by Targeting Aging-Related Mechanisms (U01 Clinical Trial Required) |
93.866 |
RFA-AG-22-011 |
| Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional) |
93.350 |
RFA-TR-21-009 |
| Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed) |
93.279 |
RFA-DA-22-004 |
| Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed) |
93.121, 93.213, 93.242, 93.279, 93.307, 93.361, 93.399, 93.846, 93.853, 93.865, 93.866, 93.867 |
PAR-21-145 |
| Cooperative Agreement for CESU-affiliated Partner with Californian Cooperative Ecosystem Studies Unit |
15.808 |
G21AS00309 |
| Limited Competition for the Continuation or Revision of Multisite Clinical Trial Clinical Coordinating Center (Collaborative UH3 Clinical Trial Optional) |
93.213 |
PAR-21-117 |
| Limited Competition for the Continuation of Multisite Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Optional) |
93.213 |
PAR-21-116 |
| Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) |
93.121, 93.213, 93.242, 93.279, 93.307, 93.361, 93.399, 93.853, 93.865, 93.866, 93.867 |
PAR-21-144 |
| The Cellular Scale Connectome in Aging and Alzheimers Disease (U01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-22-008 |
| NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed) |
93.866 |
PAR-20-317 |
| NIH Blueprint for Neuroscience Research: Tools and Technologies to Explore Nervous System Biomolecular Condensates (R21 Clinical Trial Not Allowed) |
93.113, 93.121, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-DA-22-008 |
| NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed) |
93.853 |
PAR-21-114 |
Search Results 3201-3240 of 15496
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 [Next] |
